On March 28, 2024, as the final drop of product was successfully harvested, BiBo achieved an industry marvel—”Right on the First Time, Success on the First Time” in process scale-up production on its newly operational 30,000-liter production platform! This milestone not only marks the official industrialization of the world’s fourth-generation bioreactor but also solidifies BiBo’s global leadership in the fourth wave of biopharmaceutical manufacturing.

“Step by step, the effort never fails; drop by drop, the river fills.” Building on the inaugural success of its 30,000L production line, BiBo has embarked on a new decade-long journey of innovation.

Over the past year, upholding its pioneering and results-driven Can-Do spirit, BiBo has successfully scaled up processes for three products to its 30,000-liter ultra-large-scale production line, not only achieving ” Right on the First Time, Success on the First Time ” in production scale-up for all products, but also maintaining a 100% success rate across all batches during subsequent GMP production at this ultra-large scale throughout the year, while surpassing laboratory benchmarks in multiple critical parameters, demonstrating exceptional process robustness and outstanding large-scale production capabilities.

These achievements demonstrate exceptional process robustness and large-scale production capabilities, serving as a testament to BiBo’s seamless “Engineering-Technology-Operation” collaboration and further strengthening its competitive edge in worldwide affordability and accessibility of biologics.